Home
News
299
Results found
-
Lygature Newsletter Q4 2024
We are pleased to share the latest edition of the Lygature newsletter, showcasing key achievements and highlights from Q4 2024. -
RSNN celebrates its 10 year anniversary in 2025
The Lygature coordinated Regulatory Science Network Netherlands (RSNN) will celebrate its 10 year anniversary in 2025. Over the past 10 years the RSNN has successfully brought relevant stakeholders together around important regulatory topics, and has contributed to setting the agenda for regulatory innovation in the Netherlands and internationally. -
Lygature concludes role in Oncode Accelerator after successful startup phase
After 2.5 intense and productive years, Lygature’s involvement in Oncode Accelerator comes to an end. We are confident that the program is now fully equipped to execute its purpose: to accelerate preclinical cancer therapy development. -
Article published in Drug Discovery Today: Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?
"A more high-level definition would be preferred while allowing further specification" -
Educate. Advocate. Act Now: Addressing Antimicrobial Resistance through Public-Private Partnerships
World Antimicrobial (AMR) Awareness Week (18-24 November) is a global campaign led by the World Health Organization (WHO) to raise awareness of AMR and reduce the spread of drug-resistant infections. Lygature proudly supports this goal. -
Register now for Lygature LIVE
Registration is now open for the festive third edition of Lygature LIVE, which will take place on 19 March 2025 (15:00-20:00 including dinner), at Villa Jongerius in Utrecht. -
Lygature Newsletter: Q3, 2024
Catch up on the latest news from Lygature in the latest edition of our Quarterly Newsletter. -
GNA NOW Annual Meeting & Expert Meeting
September was a busy month for Lygature's GNA NOW Consortium, as partners gathered in Porto, Portugal, for the Annual Consortium Meeting. -
Lygature-facilitated ILLUMINATE project kicks off its activities
International consortium launches its activities to improve the approach to theranostics-based advanced stage cancer treatment while increasing the overall availability of radioisotopes. -
EFPIA report published on the value assessment of data disclosure
Recently, Lygature was asked by EFPIA to perform an impact assessment of current clinical data disclosure activities on public health. Following up on that request, our colleagues Pieter Stolk and Sophie Huiskes-Berends produced a report titled: ‘A landscape analysis for responsible transparency and clinical data disclosure for interventional studies in Europe and beyond’. -
Building Momentum in Tuberculosis Research: KITT Kicks-Off
For the second time in one year, Lygature colleagues were back in Annecy, France over the summer. This time, for the kick-off of a new initiative in the tuberculosis (TB) research space called KITT. -
IHI Masterclass on Data Sharing: Recording now available
On 4 September, Lygature Senior Program Manager Jan-Willem Boiten participated in an Innovative Health Initiative (IHI) Masterclass that introduced participants to practical tools and tips for sharing data in collaborative health projects. -
Sustainable funding schemes required to preserve Research & Development capacity for Antimicrobial Resistance
The threat of antimicrobial resistance (AMR) poses a significant global health risk. In the lead-up to the United Nations (UN) High-Level Meeting on AMR later this week, a coalition of nine European initiatives, including the GNA NOW Consortium, is calling for sustained investment in antibiotic research and development. -
Upcoming Masterclass: Unlocking the Potential of Data Sharing in Collaborative Projects
The Innovative Health Initiative (IHI) has released a new Data Sharing Playbook – an important new resource aimed at improving data-sharing practices within multi-stakeholder projects such as those under the IMI/IHI framework. Developed with contributions from Lygature, the Playbook addresses the complexities of data sharing that often hinder collaborative progress. -
Announcing the EPND Call for Expressions of Interest
The European Platform for Neurodegenerative Diseases (EPND) announces the opening of the call for expressions of interest. Applications are welcomed from investigators in academia or industry, with a proven track record in the neurodegenerative disease field.